Evidence map›Paper›PMID 21525507›Full record

ArticleDiabetes2011

Magnetic resonance spectroscopy studies of human metabolism.

Douglas E Befroy, Gerald I Shulman

Abstract read
In one paragraph

Article in Diabetes, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed.

  1. The effects of tesamorelin on phosphocreatine recovery in obese subjects with reduced GH.The Journal of clinical endocrinology and metabolism · 2014
    Trial
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Muscle Ultrasound: A Novel Noninvasive Tool for Early Detection of Developing Insulin Resistance and Lower Muscle Mass in Obesity.Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine · 2025
    Article
  7. Article
  8. FunctionalNMR in biomedicine · 2025
    Article
  9. Article
  10. Biophotonics discovery · 2024
    Article
  11. Article
  12. Article
  13. Review
  14. Metabolic Imaging in Cardio-oncology.Journal of cardiovascular translational research · 2020
    Review
  15. Imaging Cancer Metabolism: Underlying Biology and Emerging Strategies.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Review
  16. Article
  17. Review
  18. Review
  19. On the Accuracy ofFrontiers in behavioral neuroscience · 2017
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Douglas E BefroyDepartment of Diagnostic Radiology, Yale University School of Medicine, New Haven, Connecticut, USA. douglas.befroy@yale.edu
Gerald I Shulman

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Richard A Flavell · 1993 to 2026
$44.0M
Mechanisms of Lipid-Induced Hepatic Insulin ResistanceR01DK040936 · NIDDK · YALE UNIVERSITY · PI SHULMAN, GERALD I · 1989 to 2015
$5.1M
Howard Hughes Medical InstituteNIDDK NIH HHS P30 DK045735NIDDK NIH HHS R01 DK040936
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

MetabolismHumansMagnetic Resonance Spectroscopy

Identifiers

PMID21525507
PMCPMC3292308

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.